-
Signature
-
Kaushik Ghoshal, Chief Commercial Officer, SaaS business
-
Issuer symbol
-
RMD
-
Transactions as of
-
11 Oct 2024
-
Net transactions value
-
-$582,938
-
Form type
-
4
-
Filing time
-
15 Oct 2024, 10:06:52 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$432,986 |
+4,260 |
+20% |
$101.64 |
26,048 |
11 Oct 2024 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Sale |
$1,015,925 |
-4,260 |
-16% |
$238.48 |
21,788 |
11 Oct 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-4,260 |
-100% |
$0.000000 |
0 |
11 Oct 2024 |
ResMed Common Stock |
4,260 |
$101.64 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: